Table 1.
Pooled relative risks of CVDs and all-cause mortality by blood TG levels
| N |
Overall effects |
I
2
|
P for heterogeneity |
Begg’s test |
Influence analyses |
|||
|---|---|---|---|---|---|---|---|---|
| RR (95% CIs) † | P | (%) | (P value) | Minimum | Maximum | |||
| Cardiovascular disease mortality | ||||||||
| TG groups, mg/dl | ||||||||
| <90 |
10 |
0.83 (0.75, 0.93) |
0.001 |
21.6 |
0.244 |
0.592 |
0.80 (0.71, 0.91) |
0.85 (0.76, 0.94) |
| 90-150 |
12 |
1.00 (referent) |
|
|
|
|
|
|
| 150-200 |
12 |
1.15 (1.03, 1.29) |
0.015 |
22.5 |
0.222 |
0.150 |
1.12 (1.00, 1.27) |
1.19 (1.08, 1.32) |
| >200 |
8 |
1.25 (1.05, 1.50) |
0.013 |
66.2 |
0.004 |
0.711 |
1.22 (1.00, 1.49) |
1.33 (1.13, 1.57) |
| Per 1 mmol/L TG |
22 |
1.13 (1.07, 1.19) |
0.000 |
65.9 |
0.000 |
1.000 |
1.11 (1.06, 1.17) |
1.14 (1.08, 1.20) |
| Per 1ln (mmol/L TG) |
9 |
1.16 (1.05, 1.29) |
0.004 |
32.3 |
0.160 |
0.754 |
1.06 (1.02,1.11) |
1.24 (1.11, 1.39) |
| All-cause mortality | ||||||||
| TG groups, mg/dl |
|
|
|
|
|
|
|
|
| <90 |
12 |
0.94 (0.85, 1.03) |
0.150 |
71.1 |
0.000 |
0.732 |
0.90 (0.83, 0.97) |
0.96 (0.84, 1.06) |
| 90-150 |
14 |
1.00 (referent) |
|
|
|
|
|
|
| 150-200 |
14 |
1.09 (1.02, 1.17) |
0.011 |
33.3 |
0.108 |
1.000 |
1.08 (1.00, 1.16) |
1.11 (1.04, 1.19) |
| 00A0 > 200 |
8 |
1.20 (1.04, 1.38) |
0.011 |
75.4 |
0.000 |
0.711 |
1.17 (1.01, 1.35) |
1.25 (1.14, 1.37) |
| Per 1 mmol/L TG |
22 |
1.12 (1.07, 1.16) |
0.000 |
75.9 |
0.000 |
0.866 |
1.11 (1.07, 1.15) |
1.13 (1.08, 1.18) |
| Per 1 ln (mmol/L TG) | 8 | 1.11 (1.01, 1.23) | 0.030 | 62.4 | 0.010 | 0.711 | 1.08 (0.99, 1.18) | 1.14 (1.02, 1.28) |
† Random-effects model.
RR, relative risk; CI, confidence interval; TG: triglycerides; CVDs: cardiovascular diseases.